The Blood Grouping Reagents Market in Australia has exhibited a significant downward trend over the past decade, starting from a value of 27.203 million USD in 2012 to 11.218 million USD in 2022. The market peaked in 2013 with a value of 29.476 million USD; however, it experienced steep declines thereafter. Early years like 2016 and 2017 saw abrupt drops of -22.82% and -20.86%, while the fall rate decelerated in recent years to -8.16% in 2021 and -8.71% in 2022. The compound annual growth rate (CAGR) from 2017 to 2022 was -8.41%, highlighting a consistent negative trend.
Future trends to watch for:
- Emerging technologies in diagnostics and automation that could stabilize or boost market demand.
- Regulatory changes and healthcare policies affecting procurement and usage of blood grouping reagents.
- Potential uptick driven by advancements in personalized medicine requiring precise blood typing.
- Competitive dynamics with new entrants and innovations in blood grouping methodologies.
| # | 16 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 China | 352,470,000 | 2023 | +3.9% | +3.83% | View data |
| 2 | 2 United Kingdom | 110,710,000 | 2023 | +1.38% | +3.83% | View data |
| 3 | 3 Spain | 103,550,000 | 2023 | +3.37% | +4.68% | View data |
| 4 | 4 Italy | 95,043,000 | 2023 | +1.51% | +1.53% | View data |
| 5 | 5 Brazil | 35,183,000 | 2023 | -3.18% | -3.78% | View data |
| 7 | 7 Thailand | 20,590,000 | 2023 | +5.58% | +6.99% | View data |
| 8 | 8 Greece | 14,156,000 | 2023 | -1.36% | -2.09% | View data |
| 9 | 9 Australia | 10,169,000 | 2023 | -9.35% | -7.54% | |
| 10 | 10 Hungary | 8,505,100 | 2023 | +0.8% | -2.77% | View data |
| 11 | 11 Portugal | 8,140,900 | 2023 | -11.08% | -6.98% | View data |
